You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
15 October 2020
HRA Pharma’s ellaOne brand has become the first emergency contraceptive pill in Italy to be made available without a prescription to women under 18 years of age. David Wright, HRA Pharma’s chief executive officer, described the development as a “milestone achievement”.
12 March 2020
Acquiring the Mederma skincare brand helped HRA Pharma increase its worldwide sales by 21% to EUR254 million (USD279 million) in 2019.
14 January 2020
France’s HRA Pharma is stepping up its presence in China through a new subsidiary in Shanghai and a joint venture with specialty healthcare company Profex.
19 December 2019
France's HRA Pharma is expanding into the Middle East with its Compeed blister care brand.
3 December 2019
HRA Pharma’s new multi-country marketing campaign for its ellaOne (ulipristal acetate) emergency contraceptive captures the OTCToolbox Consumer Healthcare Industry (CHi) Award for European Marketing Campaign of the Year.
15 July 2019
HRA Pharma has put its medicines for rare diseases into a separate affiliate, as the French company focuses on expanding its consumer healthcare business.
29 April 2019
France's HRA Pharma is set to acquire global rights to the Mederma skincare brand from Merz Pharmaceuticals for an undisclosed sum. The deal also includes the Eldertonic and Nu-Iron vitamins, minerals and supplements (VMS) brands.
9 April 2019
A recent hackathon organised by HRA Pharma produced 14 potential digital solutions that could improve the contraception journey for women.
5 April 2019
Acquiring the Compeed brand helped HRA Pharma increase its worldwide sales by 72% to EUR210 million (USD237 million) in 2018.